Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Müller T, Barghorn S, Lütge S, Haas T, Mueller R, Gerlach B, Ohm G, Eilert K, Trommer I, Mueller BK